{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:14:59Z","timestamp":1779290099104,"version":"3.51.4"},"publisher-location":"Chichester, UK","reference-count":24,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004524.pub2","type":"reference-entry","created":{"date-parts":[[2004,7,21]],"date-time":"2004-07-21T07:08:53Z","timestamp":1090393733000},"source":"Crossref","is-referenced-by-count":10,"title":["Methotrexate for ankylosing spondylitis"],"prefix":"10.1002","author":[{"given":"J","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD004524.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/030097401753180318","article-title":"Clinical investigation of methotrexate in the treatment of ankylosing spondylitis","volume":"30","author":"Altan","year":"2001","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/rheumatology\/41.11.1330","article-title":"Is methotrexate effective in ankylosing spondylitis?","volume":"41","author":"Roychowdhury","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"supplement 1","key":"10.1002\/14651858.CD004524.pub2-BIB3|cit3","first-page":"43","article-title":"Methotrexate in severe ankylosing spondylitis: A randomised placebo controlled , double-blind observer study","volume":"40","author":"Roychowdhury","year":"2001","journal-title":"Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/art.10148","article-title":"Guidelines for the management of rheumatoid arthritis","volume":"46","year":"2002","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD004524.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s100670050027","article-title":"Efficacy of methotrexate in the treatment of ankylosing spondylitis: a three-year open study","volume":"19","author":"Biasi","year":"2000","journal-title":"Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD004524.pub2-BIB7|cit7","first-page":"45","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"37","author":"Clavaguera","year":"1998","journal-title":"British Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD004524.pub2-BIB8|cit8","first-page":"1104","article-title":"Methotrexate in severe ankylosing spondylitis: an open study","volume":"22","author":"Creemers","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/rheumatology\/37.5.502","article-title":"Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis","volume":"37","author":"Dolhain","year":"1998","journal-title":"British Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB10|cit10","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0950-3579(98)80046-0","article-title":"Spondyloarthropathy treatment: progress in medical therapy","volume":"12","author":"Dougados","year":"1998","journal-title":"Bailliere's clinical rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"iii40","DOI":"10.1136\/ard.61.suppl_3.iii40","article-title":"Conventional treatments for ankylosing spondylitis","volume":"61(Suppl III)","author":"Dougados","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD004524.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD004524.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/anr.1780320221","article-title":"Favourable results using methotrexate in the treatment of patients with ankylosing spondylitis","volume":"32","author":"Handler","year":"1989","journal-title":"Arthritis & Rheumatism"},{"key":"10.1002\/14651858.CD004524.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004524.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","article-title":"Update on spondyloarthropathies","volume":"136","author":"Khan","year":"2002","journal-title":"Annals of Internal Medicine"},{"issue":"supplement 59","key":"10.1002\/14651858.CD004524.pub2-BIB16|cit16","first-page":"57","article-title":"Efficacy and side effects of low dose methotrexate treatment in the patients with ankylosing spondylitis","volume":"27","author":"Kirnap","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB17|cit17","first-page":"1431","article-title":"Management of rheumatoid arthritis: the historical context","volume":"28","author":"Moreland","year":"2001","journal-title":"Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/berh.2002.0263","article-title":"Seronegative spondyloarthritides","volume":"16","author":"Olivieri","year":"2002","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00124743-199806000-00007","article-title":"Methotrexate lacks efficacy in the treatment of severe ankylosing spondylitis compared with rheumatoid and psoriatic arthritis","volume":"4","author":"Ostendorf","year":"1998","journal-title":"Journal of Clinical Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1080\/030097400750002021","article-title":"Methotrexate in the treatment of ankylosing spondylitis","volume":"29","author":"Sampaio-Barros","year":"2000","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1136\/ard.61.suppl_3.iii1","article-title":"New treatment strategies in ankylosing spondylitis: Proceeding of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 Janeary 2002","volume":"61(Suppl III)","author":"Sieper","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD004524.pub2-BIB22|cit22","article-title":"Methotrexate for treating rheumatoid arthritis","author":"Suarez-Almazor","year":"2003","journal-title":"The Cochrane Library"},{"key":"10.1002\/14651858.CD004524.pub2-BIB23|cit23","first-page":"495","article-title":"Which domains slould be included in a core set for endpoints in ankylosing spondylitis? Introduction to the ankylosing spondylitis module of OMERACT IV","volume":"26","author":"Heijde","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD004524.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"iii24","DOI":"10.1136\/ard.61.suppl_3.iii24","article-title":"Treatment trials in ankylosing spondylitis: current and future considerations","volume":"61(Suppl III)","author":"Heijde","year":"2002","journal-title":"Annals of the Rheumatic Diseases"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD004524.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T21:36:27Z","timestamp":1628544987000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004524.pub2"}},"subtitle":[],"editor":[{"given":"Junmin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004524.pub2","relation":{},"subject":[],"published":{"date-parts":[[2003,7,21]]}}}